A vial labeled "30 mg" might contain 30 mg total in 3 mL (concentration: 10 mg/mL) or 30 mg total in 1 mL (concentration: 30 mg/mL)
While BPC-157 research focuses on localised repair mechanisms and growth factor upregulation, TB-500 research centres on cell migration and anti-inflammatory pathways
Benefits AOD-9604 is believed to help with: Mechanistically designed to support fat breakdown and reduce new fat formation while having minimal direct impact on blood sugar and IGF1. May offer modest additional help with fat metabolism when combined with calorie control and exercise, particularly in higheradiposity individuals. Typically administered as a daily subcutaneous injection in low doses, integrated into a broader metabolic and lifestyle protocol. Longterm clinical safety data show generally good tolerability in studied populations, but regulators have highlighted unresolved immunogenicity and impurity concerns, so usage must remain cautious and fully consented. Positioned as an optional, supportive layernot a standalone weight-loss solutionwith emphasis on lab monitoring, habit coaching, and realistic expectations.
Caregivers of people living with dementia report providing 27 hours more care per month on average (92 hours versus 65 hours) than caregivers of people without dementia
The discovery of the Innate Repair Receptor turned our understanding of inflammation on its head
Contact us with your order number to request batch-specific documentation
